Proving AI ROI in Pharma Marketing - with Kellen Winters of Novartis

Welcome, everyone, to the Emerge AI in Business podcast. Kellan joins us today to discuss why proving the value of AI investments begins with measurement, establishing a data-driven baseline and anchoring each use case in the business problems where work stalls before any technology is selected.

It goes beyond the title with direct discussion of really, think, it's, including: Today's guest is Kellan Winters, Director of Customer Success and Business Operations for AI at Novartis.

1. 01Kellan joins us today to discuss why proving the value of AI investments begins with measurement, establishing a data-driven baseline and anchoring each use case in the business pr
2. 02Just a quick note for our audience that the views and opinions expressed by Kellen on today's program are her own and do not reflect those of Novartis or its leadership
3. 03Would you say the resistance is more about the money spent or more about the admitting that it wasn't monitored?